Search

Displaying results 8901 - 8910 of 10000 in total
  1. Drug

    Levofacetoperane

    go.drugbank.com/drugs/DB19849
    Experimental

    Levofacetoperane is a small molecule drug. Levofacetoperane has a monoisotopic molecular weight of 233.14 Da.

    Categories: Heterocyclic Compounds, 1-RingSynonyms: (r,r)-(-)-phacetoperane
  2. Drug

    Cinoxopazide

    go.drugbank.com/drugs/DB19851
    Experimental

    Cinoxopazide is a small molecule drug. Cinoxopazide has a monoisotopic molecular weight of 371.18 Da.

  3. Drug

    Flesinoxan

    go.drugbank.com/drugs/DB19853
    Experimental

    Flesinoxan is a small molecule drug. The usage of the INN stem '-oxan(e)' in the name indicates that Flesinoxan is a benzodioxane derivative. … Flesinoxan has a monoisotopic molecular weight of 415.19 Da.

    Categories: Heterocyclic Compounds, 1-Ring
  4. Drug

    Iprotiazem

    go.drugbank.com/drugs/DB19857
    Experimental

    Iprotiazem is a small molecule drug. Iprotiazem has a monoisotopic molecular weight of 647.34 Da.

  5. Drug

    Betamipron

    go.drugbank.com/drugs/DB19858
    Experimental

    Betamipron is a small molecule drug. Betamipron has a monoisotopic molecular weight of 193.07 Da.

    Synonyms: N-benzoyl-.beta.-alanine
  6. Drug

    Dichlorophenarsine

    go.drugbank.com/drugs/DB19861
    Experimental

    Dichlorophenarsine is a small molecule drug. Dichlorophenarsine has a monoisotopic molecular weight of 252.9 Da.

  7. Drug

    MIP-1095 I-131

    go.drugbank.com/drugs/DB14978
    Investigational

    MIP-1095 I-131 is under investigation in clinical trial NCT03030885 (Use of an Experimental Radiopharmaceutical (131I-MIP-1095) in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC)).

  8. Drug

    Martinostat

    go.drugbank.com/drugs/DB14979
    Investigational

    Martinostat is under investigation in clinical trial NCT03721211 (Imaging With [11C]Martinostat in Breast Cancer).

  9. Drug

    Nomacopan

    go.drugbank.com/drugs/DB14991
    Investigational

    Nomacopan is under investigation in clinical trial NCT03427060 (Coversin in PNH in Patients With Resistance to Eculizumab Due to Complement C5 Polymorphisms).

    Categories: Recombinant Protein Inhibitor of Complement Factor 5
  10. Drug

    Pegunigalsidase alfa

    go.drugbank.com/drugs/DB14992
    ApprovedInvestigational

    Pegunigalsidase alfa (PRX-102) is a recombinant form of human α-galactosidase-A indicated for long-term enzyme replacement therapy in patients with Fabry disease, a rare genetic disorder characterized … to a different glycosylation pattern.